Assessment of Tumor Infiltrating Lymphocytes in Predicting Stereotactic Ablative Radiotherapy (SABR) Response in Unresectable Breast Cancer
Background: Patients with advanced breast cancer (BC) may be treated with stereotactic ablative radiotherapy (SABR) for tumor control. Variable treatment responses are a clinical challenge and there is a need to predict tumor radiosensitivity a priori. There is evidence showing that tumor infiltrati...
Saved in:
| Main Authors: | Mateusz Bielecki, Khadijeh Saednia, Fang-I Lu, Shely Kagan, Danny Vesprini, Katarzyna J. Jerzak, Roberto Salgado, Raffi Karshafian, William T. Tran |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Radiation |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-592X/5/2/11 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer
by: Anna-Lena Zang, et al.
Published: (2025-09-01) -
MODERN METHODS OF TREATMENT OF RECURRENT UNRESECTABLE SQUAMOUS CELL CARCINOMA OF LARYNX (LITERATURE REVIEW)
by: V. A. Rozhnov, et al.
Published: (2016-07-01) -
Ablative Techniques for Lung Metastases: Patient Selection and Outcomes Following Treatment with Stereotactic Radiotherapy or Radiofrequency Ablation
by: Jennifer W. S. Pang, et al.
Published: (2025-05-01) -
Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey
by: Katherine Taplin, et al.
Published: (2025-01-01) -
Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
by: Anna Zygogianni, et al.
Published: (2025-02-01)